Compare Crispr Therapeutics AG (CRSP) vs Direxion Daily Semiconductor Bull 3X Shares (SOXL) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Crispr Therapeutics AG vs Direxion Daily Semiconductor Bull 3X Shares — how do they compare? Crispr Therapeutics AG trades at $53.39 (market cap $4.88B), while Direxion Daily Semiconductor Bull 3X Shares trades at $139.76 (market cap $24.42B). The key difference: Direxion Daily Semiconductor Bull 3X Shares is far larger — about 5× Crispr Therapeutics AG's market cap, and Direxion Daily Semiconductor Bull 3X Shares is trading nearer its 52-week high, Crispr Therapeutics AG nearer its low. Which is the better fit depends on your goals — on Pluang, investors hold Crispr Therapeutics AG for 77 Days and Direxion Daily Semiconductor Bull 3X Shares for 15 Days on average.
| CRSP | SOXL | |
|---|---|---|
Market Cap | $4.88B | $24.42B |
Volume | 2,861,747 | 100,232,380 |
Sector | Health | Leveraged / Inverse |
52-Week High | $74.92 | $300.77 |
52-Week Low | $44.34 | $30.81 |
Typical Hold Time | 77 Days | 15 Days |
Enterprise Value | $3.30B | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
CRISPR Therapeutics (CRSP) trades at $50.44, down 3.65% amid bearish technical signals. The company shows negative profitability with -$581.60M net income and -4,101.26% net margin for 2025, though Q2 2026 EPS beat expectations. Positive analyst sentiment persists with 57.9% buy ratings and $67.83 consensus target. Recent clinical data presentations and CASGEVY commercial progress provide catalysts.
The stock faces fundamental challenges with persistent losses and negative cash flow from operations, but maintains Wall Street support for its gene-editing pipeline. Key risks include clinical trial outcomes and cash burn, while potential upside hinges on successful drug commercialization and upcoming data readouts through 2026.
SOXL, the Direxion Daily Semiconductor Bull 3X ETF, is trading at $142.52, down 10.31% with a bearish technical signal. The semiconductor sector faces volatility, with mixed news including recent chip stock rallies and concerns about AI funding and regulatory tariffs. Technical indicators show neutral oscillators but bearish overall momentum, with key support at $134 and resistance at $153.
Outlook remains cautious due to leveraged ETF risks and semiconductor sector volatility. Investment opportunity exists for bullish semiconductor bets amid strong AI demand, but risks include high leverage decay, regulatory headwinds, and crowded trading positioning. Timing is critical given recent sharp rebounds and potential near-term drawdowns.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Crispr Therapeutics AG
CRISPR Therapeutics is a gene editing company focused on the development of CRISPR/Cas9-based therapeutics. CRISPR/Cas9 stands for Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR)/CRISPR-associated protein 9 (Cas9), which is a revolutionary technology for precisely altering specific sequences of genomic DNA. The company is focused on using this technology to treat genetically defined diseases. CRISPR's most advanced pipeline candidate, CTX001, is in collaboration with Vertex Pharmaceuticals and targets sickle cell disease and transfusion-dependent beta-thalassemia, which have high unmet medical needs. The company is progressing additional gene editing programs for immuno-oncology, as well as a stem cell-derived therapy for the treatment of Type 1 diabetes.
Read more on CRSP →About Direxion Daily Semiconductor Bull 3X Shares
SOXL is a leveraged ETF that seeks daily investment results corresponding to 300% of the daily performance of the ICE Semiconductor Index. It is designed as a tactical tool for experienced traders to take a bullish (long) position on the semiconductor sector. Due to the effects of compounding and leverage, the ETF is intended to be held for a single day and is not suitable for long-term investment.
Read more on SOXL →
